Purpose of Review
Research over the past few decades points to the importance of
frailty, or the lack of physiologic reserve, in the natural history of
chronic diseases and in modifying the impact of potential interventions.
End-stage kidney disease (ESKD) and the intervention of kidney
transplantation are no exception. We review the recent epidemiologic and
cohort-based evidence on the association between frailty and kidney
transplant outcomes and provide a framework of questions with which to
approach future research endeavors and clinical practice.
Recent Findings
Frailty in kidney transplant candidates can be measured in numerous
ways, including descriptive phenotype, description scores, functional
testing, and surrogate measures. Regardless of the metric, the presence of
frailty is strongly associated with inferior pre- and posttransplant
outcomes compared to the absence of frailty. However, some frail patients
with ESKD can benefit from transplant over chronic dialysis. Evidence-based
approaches for identifying frail ESKD patients who can benefit from
transplant over dialysis, with acceptable posttransplant outcomes, are
lacking. Interventional trials to improve frailty and physical function
before transplant (prehabilitation) and after transplant (rehabilitation)
are also lacking.
Conclusion
Frailty is increasingly recognized as highly relevant to
peritransplant outcomes, but more work is needed to: 1) tailor management to
the unique needs of frail patients, both pre- and posttransplant; 2) define
phenotypes of frail patients who are expected to benefit from transplant
over dialysis; and 3) develop interventions to reverse frailty, both pre-
and post-transplant.